For over a century, acute 'post-streptococcal glomerulonephritis' (APSGN) was the prototypical form of bacterial infection-associated glomerulonephritis, typically occurring after resolution of infection and a distinct infection-free latent period.
This guideline covers recognising, diagnosing and managing bacterial meningitis and meningococcal septicaemia (blood poisoning) in babies, children and young people under 16.
The FDA has authorized marketing of the Cobas vivoDx MRSA diagnostic test, from Roche, based on bacterial viability and novel...
Objective: We hypothesized that distinct nasal airway microbiota structures also exist in children with asthma and relate to clinical outcomes.
Glomerulonephritis, secondary to bacterial, or, more rarely, viral or parasitic infections, is called infection-associated. The epidemiology of infection-associated glomerulonephritis has changed in recent decades.
The scope of this guideline covers the recognition and management of serious bacterial illness in the antenatal and intrapartum periods, arising in the genital tract or elsewhere, and its management in secondary care.
Identifying trigger will hopefully help future development of targeted therapy for patients suffering from this debilitating disease
This guideline covers diagnosing and managing first or recurrent upper or lower urinary tract infections in infants, children and young people. It aims to achieve more consistent clinical practice, based on accurate diagnosis and effective...
The FDA approved sulbactam and durlobactam (SUL+DUR; Xacduro, Innoviva Specialty Therapeutics) co-packaged for IV use to treat hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP) caused by susceptible strains of Acinetobacter baumannii–calcoaceticus complex
RedHill Biopharma has announced successful final results from the first Phase III clinical study with RHB 105 for the eradication...